Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $149000.0.

  • Neurogene's Other Non Operating Income rose 419.58% to $149000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 9015.19%. This contributed to the annual value of $574000.0 for FY2024, which is 9649.04% down from last year.
  • As of Q3 2025, Neurogene's Other Non Operating Income stood at $149000.0, which was up 419.58% from $1.2 million recorded in Q2 2025.
  • Neurogene's 5-year Other Non Operating Income high stood at $16.4 million for Q4 2023, and its period low was $143000.0 during Q1 2024.
  • Moreover, its 3-year median value for Other Non Operating Income was $146000.0 (2024), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Neurogene's Other Non Operating Income crashed by 9911.95% in 2024, and later soared by 74166.67% in 2025.
  • Neurogene's Other Non Operating Income (Quarter) stood at $16.4 million in 2023, then plummeted by 99.12% to $144000.0 in 2024, then increased by 3.47% to $149000.0 in 2025.
  • Its Other Non Operating Income stands at $149000.0 for Q3 2025, versus $1.2 million for Q2 2025 and $148000.0 for Q1 2025.